Pancreatic Cancer
PEGPH20 for Stage IV Previously Untreated Pancreatic Cancer (2542.00)
A Phase 1b/2 Multicenter, International, Randomized, Double Blind, Placebo-Controlled, Study of Gemcitabine (Gemzar) Combined With PEGPH20 Compared to Gemcitabine Combined With Placebo in Patients With Stage IV Previously Untreated Pancreatic Cancer
Investigator: Sunil Hingorani, MD, PhD; Conditions: Pancreatic Cancer; Status: Recruiting; Study ID: NCT01453153
A Phase II Study Induction Chemotherapy, Neoadjuvant Chemoradiotherapy, Surgical Resection and Adjuvant Chemotherapy for Patients with Locally Advanced, Resectable Pancreatic Adenocarcinoma
Investigator: Samuel Whiting, MD, PhD; Conditions: Pancreatic Cancer; Status: Recruiting; Study ID: NCT00609336
A Randomized Phase III Study of Weekly ABI-007 (Abraxane) plus Gemcitabine (Gemzar) versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Investigator: Sunil Hingorani, MD, PhD; Conditions: Pancreatic Cancer; Status: Closed; Study ID: NCT00844649
A Phase III Study of Chemotherapy and Chemoradiotherapy With or Without HyperAcute®-Pancreatic Cancer Vaccine in Subjects with Surgically Resected Pancreatic Cancer
Investigator: Samuel Whiting, MD, PhD; Conditions: Pancreatic Cancer; Status: Recruiting; Study ID: NCT01072981
Join Us On